A SERS-active plasmonic nanosensor-chemometrics platform reveals a biphasic zinc switch that controls breast-cancer metastasis

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Zhou, Ting
  • dc.contributor.author Rodríguez-Barrios, Suliany
  • dc.contributor.author Ruisánchez, Itziar
  • dc.contributor.author Rivera Gil, Pilar, 1976-
  • dc.date.accessioned 2025-11-07T16:52:57Z
  • dc.date.available 2025-11-07T16:52:57Z
  • dc.date.issued 2025
  • dc.date.updated 2025-11-07T16:52:57Z
  • dc.description.abstract Labile Zn2+ is emerging as a quantitative driver, not just a biomarker, of metastasis, yet rapid, second-resolved intracellular measurement remains elusive. Here we engineer terpyridine-functionalised, hollow Au@SiO2 nanocapsules (NCs@TPY) and couple their SERS signal to cell-specific partial-least-squares (PLS) chemometrics, yielding an 8-log dynamic range (10-12 - 10-4 M), a low-nanomolar detection limit and ≤4.5 % cross-validated error while rejecting Ca2+/Mg2+ interference. Applying this platform to four breast-cancer lines reveals that basal cytosolic Zn2+ forms a "ladder" paralleling metastatic aggressiveness (MCF-7 25 pM < MDA 430 pM < LM2 4.7 nM < BrM2 51 nM). Manipulating extracellular zinc uncovers a biphasic switch: migration, invasion and proliferation all peak when intracellular Zn2+ rises into the nanomolar band (∼10-560 nM) and collapse once it exceeds ∼5-70 μM (line-specific). Primary-tumour-derived MDA cells are hypersensitive, reaching maximal metastatic traits at ∼0.6 μM Zn2+, whereas lung- and brain-tropic variants show partial resistance, indicating micro-environmental adaptation. The NCs@TPY-PLS assay thus provides the first tool to track intracellular zinc across eight orders of magnitude in situ and demonstrates that tightly regulated Zn2+ dyshomeostasis controls metastatic behaviour. Because the Raman ligand is exchangeable, the capsule architecture is readily extendable to multiplex ion or redox sensing, and the identified "functional window" positions zinc transporters as actionable targets for anti-metastatic therapy.
  • dc.description.sponsorship PRG acknowledges the Spanish Ministry of Science, Innovation and Technology (AEI-PID2022-140423NB-100/AEI/10.13039/501100011033 and CNS2023 - 143700) for funding. TZ. and PRG appreciate the financial support from the China Scholarship Council (CSC) by a State Scholarship Fund (NSCIS no. 202008350121). With the support of the Department of Research and Universities of the Generalitat of Catalonia in the Chemometrics and Sensorics for Analytical Solutions Research Group, CHEMOSENS (Code: 2021 SGR 00705).
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Zhou T, Rodriguez-Barrios S, Ruisanchez I, Rivera-Gil P. A SERS-active plasmonic nanosensor-chemometrics platform reveals a biphasic zinc switch that controls breast-cancer metastasis. Biosens Bioelectron. 2025 Dec 1;289:117897. DOI: 10.1016/j.bios.2025.117897
  • dc.identifier.doi http://dx.doi.org/10.1016/j.bios.2025.117897
  • dc.identifier.issn 0956-5663
  • dc.identifier.uri http://hdl.handle.net/10230/71813
  • dc.language.iso eng
  • dc.publisher Elsevier
  • dc.relation.ispartof Biosensors and Bioelectronics. 2025;289:117897
  • dc.relation.projectID info:eu-repo/grantAgreement/ES/3PE/PID2022-140423NB-100
  • dc.rights © 2025 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.rights.uri http://creativecommons.org/licenses/by-nc/4.0/
  • dc.subject.keyword Labile zinc
  • dc.subject.keyword Breast neoplasms-metastasis
  • dc.subject.keyword Gold-silica nanocapsules
  • dc.subject.keyword Raman spectroscopy-SERS
  • dc.subject.keyword Plasmonic nanosensor
  • dc.subject.keyword Multivariate calibration (partial least-squares chemometrics)
  • dc.subject.keyword Intracellular ion sensing
  • dc.title A SERS-active plasmonic nanosensor-chemometrics platform reveals a biphasic zinc switch that controls breast-cancer metastasis
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/publishedVersion